المؤلفون: Reinholm, Arttu, Maljanen, Sari, Jalkanen, Pinja, Altan, Eda, Tauriainen, Sisko, Belik, Milja, Skön, Marika, Haveri, Anu, Österlund, Pamela, Iakubovskaia, Alina, Pasternack, Arja, Naves, Rauno A., Ritvos, Olli, Miettinen, Simo, Häkkinen, Hanni K., Ivaska, Lauri, Tähtinen, Paula A., Lempainen, Johanna, Kantele, Anu, Kakkola, Laura, Julkunen, Ilkka, Kolehmainen, Pekka

المساهمون: Department of Physiology, Medicum, Growth factor physiology, Veterinary Biosciences, HUS Helsinki and Uusimaa Hospital District, Infektiosairauksien yksikkö, Department of Virology, Department of Medicine, HUS Inflammation Center

مصطلحات موضوعية: 3121 General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: Reinholm , A , Maljanen , S , Jalkanen , P , Altan , E , Tauriainen , S , Belik , M , Skön , M , Haveri , A , Österlund , P , Iakubovskaia , A , Pasternack , A , Naves , R A , Ritvos , O , Miettinen , S , Häkkinen , H K , Ivaska , L , Tähtinen , P A , Lempainen , J , Kantele , A , Kakkola , L , Julkunen , I & Kolehmainen , P 2024 , ' Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection ' , Communications Medicine , vol. 4 , no. 1 , 28 . https://doi.org/10.1038/s43856-024-00457-3Test; RIS: urn:9D570A9FEFF8E270B1F6A82F60063BFA; RIS: Reinholm2024; ORCID: /0009-0002-1107-522X/work/159028027; ORCID: /0000-0002-6088-4245/work/159029800; http://hdl.handle.net/10138/575007Test; 792d0022-a479-45e1-8364-07b391ebde9d; 001172587100002

الإتاحة: http://hdl.handle.net/10138/575007Test

المؤلفون: Jalkanen, Pinja, Pasternack, Arja, Maljanen, Sari, Melen, Krister, Kolehmainen, Pekka, Huttunen, Moona, Lundberg, Rickard, Tripathi, Lav, Khan, Hira, Ritvos, Mikael A., Naves, Rauno, Haveri, Anu, Osterlund, Pamela, Kuivanen, Suvi, Jaaskelainen, Anne J., Kurkela, Satu, Lappalainen, Maija, Rantasarkka, Kaisa, Vuorinen, Tytti, Hytonen, Jukka, Waris, Matti, Tauriainen, Sisko, Ritvos, Olli, Kakkola, Laura, Julkunen, Ilkka

المصدر: Journal of Infectious Diseases. 224(2):218-228

مصطلحات موضوعية: COVID-19, SARS-CoV-2, enzyme immunoassay, serology, respiratory infection, antibodies, coronavirus proteins, neutralizing antibodies

وصف الملف: print

الوصول الحر: https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-302679Test
https://doi.org/10.1093/infdis/jiab222Test

المؤلفون: Mäkelä, Anna R, Uğurlu, Hasan, Hannula, Liina, Kant, Ravi, Salminen, Petja, Fagerlund, Riku, Mäki, Sanna, Haveri, Anu, Strandin, Tomas, Kareinen, Lauri, Hepojoki, Jussi, Kuivanen, Suvi, Levanov, Lev, Pasternack, Arja, Naves, Rauno A, Ritvos, Olli, Österlund, Pamela, Sironen, Tarja, Vapalahti, Olli, Kipar, Anja, Huiskonen, Juha T, Rissanen, Ilona, Saksela, Kalle

المصدر: Mäkelä, Anna R; Uğurlu, Hasan; Hannula, Liina; Kant, Ravi; Salminen, Petja; Fagerlund, Riku; Mäki, Sanna; Haveri, Anu; Strandin, Tomas; Kareinen, Lauri; Hepojoki, Jussi; Kuivanen, Suvi; Levanov, Lev; Pasternack, Arja; Naves, Rauno A; Ritvos, Olli; Österlund, Pamela; Sironen, Tarja; Vapalahti, Olli; Kipar, Anja; Huiskonen, Juha T; Rissanen, Ilona; Saksela, Kalle (2023). Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants. Nature Communications, 14(1):1637.

مصطلحات موضوعية: Institute of Veterinary Pathology, 570 Life sciences, biology, General Physics and Astronomy, General Biochemistry, Genetics and Molecular Biology, General Chemistry, Multidisciplinary

وصف الملف: application/pdf

العلاقة: https://www.zora.uzh.ch/id/eprint/236087/1/ZORA_s41467_023_37290_6.pdfTest; info:pmid/36964125; urn:issn:2041-1723

الإتاحة: https://doi.org/10.5167/uzh-23608710.1038/s41467-023-37290-6Test
https://www.zora.uzh.ch/id/eprint/236087Test/
https://www.zora.uzh.ch/id/eprint/236087/1/ZORA_s41467_023_37290_6.pdfTest

المؤلفون: Mäkelä, Anna R., Ugurlu, Hasan, Hannula, Liina, Kant, Ravi, Salminen, Petja, Fagerlund, Riku, Mäki, Sanna, Haveri, Anu, Strandin, Tomas, Kareinen, Lauri, Hepojoki, Jussi, Kuivanen, Suvi, Levanov, Lev, Pasternack, Arja, Naves, Rauno A., Ritvos, Olli, Österlund, Pamela, Sironen, Tarja, Vapalahti, Olli, Kipar, Anja, Huiskonen, Juha T., Rissanen, Ilona, Saksela, Kalle

المساهمون: Department of Virology, Institute of Biotechnology, Helsinki Institute of Life Science HiLIFE, Departments of Faculty of Veterinary Medicine, Faculty Common Matters (Faculty of Medicine), Helsinki One Health (HOH), Viral Zoonosis Research Unit, Emerging Infections Research Group, Medicum, Veterinary Biosciences, Department of Physiology, Faculty of Medicine, Growth factor physiology, HUSLAB, Veterinary Microbiology and Epidemiology, Olli Pekka Vapalahti / Principal Investigator, HUS Diagnostic Center, Infection Biology Research Program, Kalle Saksela / Principal Investigator

مصطلحات موضوعية: Domain, 3111 Biomedicine, 11832 Microbiology and virology

وصف الملف: application/pdf

العلاقة: Mäkelä , A R , Ugurlu , H , Hannula , L , Kant , R , Salminen , P , Fagerlund , R , Mäki , S , Haveri , A , Strandin , T , Kareinen , L , Hepojoki , J , Kuivanen , S , Levanov , L , Pasternack , A , Naves , R A , Ritvos , O , Österlund , P , Sironen , T , Vapalahti , O , Kipar , A , Huiskonen , J T , Rissanen , I & Saksela , K 2023 , ' Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants ' , Nature Communications , vol. 14 , no. 1 , 1637 . https://doi.org/10.1038/s41467-023-37290-6Test; ORCID: /0000-0003-3878-9775/work/133559181; ORCID: /0000-0001-5699-214X/work/133561301; ORCID: /0000-0003-0827-122X/work/133561653; ORCID: /0000-0002-2344-2755/work/133562500; ORCID: /0000-0003-2270-6824/work/133562510; ORCID: /0000-0001-7586-7539/work/133568025; ORCID: /0000-0002-3849-7847/work/133568284; ORCID: /0009-0006-9116-6103/work/154555158; ORCID: /0000-0002-6088-4245/work/155655393; ORCID: /0000-0002-0348-7323/work/156150872; http://hdl.handle.net/10138/357152Test; d150d633-ec5a-40bd-a444-c3f4c5d8fc5e; 000959887700001

الإتاحة: http://hdl.handle.net/10138/357152Test

المؤلفون: Kolehmainen, Pekka, Huttunen, Moona, Iakubovskaia, Alina, Maljanen, Sari, Tauriainen, Sisko, Yatkin, Emrah, Pasternack, Arja, Naves, Rauno, Toivonen, Laura, Tahtinen, Paula A., Ivaska, Lauri, Lempainen, Johanna, Peltola, Ville, Waris, Matti, Kakkola, Laura, Ritvos, Olli, Julkunen, Ilkka

المساهمون: Medicum, Department of Physiology, Faculty of Medicine, Growth factor physiology

مصطلحات موضوعية: Nl63, Biomedicine

وصف الملف: application/pdf

العلاقة: Kolehmainen , P , Huttunen , M , Iakubovskaia , A , Maljanen , S , Tauriainen , S , Yatkin , E , Pasternack , A , Naves , R , Toivonen , L , Tahtinen , P A , Ivaska , L , Lempainen , J , Peltola , V , Waris , M , Kakkola , L , Ritvos , O & Julkunen , I 2023 , ' Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers ' , Scientific Reports , vol. 13 , no. 1 , 8416 . https://doi.org/10.1038/s41598-023-35471-3Test; ORCID: /0000-0002-6088-4245/work/155655394; http://hdl.handle.net/10138/563893Test; e8be055a-26d5-43f1-ac28-dd6d847eb0b2; 000995835600023

الإتاحة: http://hdl.handle.net/10138/563893Test

المؤلفون: Belik, Milja, Jalkanen, Pinja, Lundberg, Rickard, Reinholm, Arttu, Laine, Larissa, Väisänen, Elina, Skön, Marika, Tahtinen, Paula A., Ivaska, Lauri, Pakkanen, Sari H., Häkkinen, Hanni K., Ortamo, Eeva, Pasternack, Arja, Ritvos, Mikael A., Naves, Rauno A., Miettinen, Simo, Sironen, Tarja, Vapalahti, Olli, Ritvos, Olli, Österlund, Pamela, Kantele, Anu, Lempainen, Johanna, Kakkola, Laura, Kolehmainen, Pekka, Julkunen, Ilkka

المساهمون: University of Helsinki, Infektiosairauksien yksikkö, Helsinki University Hospital Area, Medicum, Department of Physiology, Faculty of Medicine, Department of Virology, HUSLAB, Helsinki One Health (HOH), Viral Zoonosis Research Unit, Emerging Infections Research Group, Veterinary Biosciences, Veterinary Microbiology and Epidemiology, Growth factor physiology, Department of Medicine

مصطلحات موضوعية: IMMUNOGENICITY, MULTICENTER, BNT162B2, 3121 General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: We thank Soili Jussila, Anne Suominen, Anne-Mari Pieniniemi, and Outi Debnam for technical assistance. This study was supported by the Academy of Finland (grant number 337530 to I.J., 336439 and 335527 to A.K., and 339512 to L.K.), Jane and Aatos Erkko Foundation (grant numbers 3067-84b53 and 5360-cc2fc to I.J., and 5359-89ef7 to O.V.), the Finnish Medical Foundation (to A.K.), the Sigrid Juselius Foundation (to I.J. and L.K.), Juho Vainio Foundation (to O.V.), and HUH Funds (TYH2021343 to O.V.).; Belik , M , Jalkanen , P , Lundberg , R , Reinholm , A , Laine , L , Väisänen , E , Skön , M , Tahtinen , P A , Ivaska , L , Pakkanen , S H , Häkkinen , H K , Ortamo , E , Pasternack , A , Ritvos , M A , Naves , R A , Miettinen , S , Sironen , T , Vapalahti , O , Ritvos , O , Österlund , P , Kantele , A , Lempainen , J , Kakkola , L , Kolehmainen , P & Julkunen , I 2022 , ' Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants ' , Nature Communications , vol. 13 , no. 1 , 2476 . https://doi.org/10.1038/s41467-022-30162-5Test; ORCID: /0000-0002-2344-2755/work/113986535; ORCID: /0000-0003-2270-6824/work/113986545; ORCID: /0000-0003-4522-5337/work/113987458; ORCID: /0000-0002-6088-4245/work/155655390; ORCID: /0009-0002-1107-522X/work/156153294; http://hdl.handle.net/10138/344286Test; b5990a41-ebea-4d23-9e51-fbe2542ffb62; 000791508600018

الإتاحة: http://hdl.handle.net/10138/344286Test

المؤلفون: Jalkanen, Pinja, Kolehmainen, Pekka, Häkkinen, Hanni K., Huttunen, Moona, Tähtinen, Paula A., Lundberg, Rickard, Maljanen, Sari, Reinholm, Arttu, Tauriainen, Sisko, Pakkanen, Sari H., Levonen, Iris, Nousiainen, Arttu, Miller, Taru, Välimaa, Hanna, Ivaska, Lauri, Pasternack, Arja, Naves, Rauno, Ritvos, Olli, Österlund, Pamela, Kuivanen, Suvi, Smura, Teemu, Hepojoki, Jussi, Vapalahti, Olli, Lempainen, Johanna, Kakkola, Laura, Kantele, Anu, Julkunen, Ilkka

المساهمون: Infektiosairauksien yksikkö, Helsinki University Hospital Area, HUMI - Human Microbiome Research, University of Helsinki, Research Programs Unit, Department of Virology, HUSLAB, Medicum, Department of Physiology, Faculty of Medicine, Growth factor physiology, Viral Zoonosis Research Unit, Helsinki One Health (HOH), Veterinary Microbiology and Epidemiology, Veterinary Biosciences, Olli Pekka Vapalahti / Principal Investigator, Department of Medicine, HUS Inflammation Center

مصطلحات موضوعية: NEUTRALIZING ANTIBODIES, INFECTION, General medicine, internal medicine and other clinical medicine, Biomedicine, 11832 Microbiology and virology

وصف الملف: application/pdf

العلاقة: We thank Soili Jussila for cell maintenance, Mikael Ritvos for assistance in protein production, and Anne Suominen, Anne-Mari Pieniniemi, and Simo Miettinen for technical assistance. I.J. was funded by Jane and Aatos Erkko Foundation (grant numbers 3067-84b53 and 5360-cc2fc), the Academy of Finland (AoF; grant numbers 336410 and 337530) and Sigrid Juselius Foundation. J.H. was funded by AoF (grant number 308613) A.K. was funded by AoF (grant numbers 336439 and 335527), the Finnish Medical Foundation, and private donors through UH. O.V., T.S., and S.K. were funded by Jane and Aatos Erkko Foundation, AoF (grant numbers 336490 to O.V.) and Helsinki University Hospital Funds (TYH2018322). P.A.T., L.I., and J.L. were funded by The Turku University Hospital Research Foundation.; Jalkanen , P , Kolehmainen , P , Häkkinen , H K , Huttunen , M , Tähtinen , P A , Lundberg , R , Maljanen , S , Reinholm , A , Tauriainen , S , Pakkanen , S H , Levonen , I , Nousiainen , A , Miller , T , Välimaa , H , Ivaska , L , Pasternack , A , Naves , R , Ritvos , O , Österlund , P , Kuivanen , S , Smura , T , Hepojoki , J , Vapalahti , O , Lempainen , J , Kakkola , L , Kantele , A & Julkunen , I 2021 , ' COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants ' , Nature Communications , vol. 12 , no. 1 , 3991 . https://doi.org/10.1038/s41467-021-24285-4Test; ORCID: /0000-0001-5699-214X/work/108863908; ORCID: /0000-0003-2270-6824/work/108864933; ORCID: /0000-0003-4522-5337/work/108866234; ORCID: /0000-0002-6088-4245/work/155655389; http://hdl.handle.net/10138/340930Test; 8b3a3a87-ef0f-48ba-b8ec-c58ae7f425ec; 000669944900001

الإتاحة: http://hdl.handle.net/10138/340930Test

المؤلفون: Jalkanen, Pinja, Kolehmainen, Pekka, Häkkinen, Hanni K, Huttunen, Moona, Tähtinen, Paula A, Lundberg, Rickard, Maljanen, Sari, Reinholm, Arttu, Tauriainen, Sisko, Pakkanen, Sari H, Levonen, Iris, Nousiainen, Arttu, Miller, Taru, Välimaa, Hanna, Ivaska, Lauri, Pasternack, Arja, Naves, Rauno, Ritvos, Olli, Österlund, Pamela, Kuivanen, Suvi, Smura, Teemu, Hepojoki, Jussi, Vapalahti, Olli, Lempainen, Johanna, Kakkola, Laura, Kantele, Anu, Julkunen, Ilkka

المصدر: Jalkanen, Pinja; Kolehmainen, Pekka; Häkkinen, Hanni K; Huttunen, Moona; Tähtinen, Paula A; Lundberg, Rickard; Maljanen, Sari; Reinholm, Arttu; Tauriainen, Sisko; Pakkanen, Sari H; Levonen, Iris; Nousiainen, Arttu; Miller, Taru; Välimaa, Hanna; Ivaska, Lauri; Pasternack, Arja; Naves, Rauno; Ritvos, Olli; Österlund, Pamela; Kuivanen, Suvi; Smura, Teemu; Hepojoki, Jussi; Vapalahti, Olli; Lempainen, Johanna; Kakkola, Laura; Kantele, Anu; Julkunen, Ilkka (2021). COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants. Nature Communications, 12(1):3991.

مصطلحات موضوعية: Institute of Veterinary Pathology, 570 Life sciences, biology, General Physics and Astronomy, General Biochemistry, Genetics and Molecular Biology, General Chemistry

وصف الملف: application/pdf

العلاقة: https://www.zora.uzh.ch/id/eprint/209420/1/41467_2021_Article_24285.pdfTest; urn:issn:2041-1723

الإتاحة: https://doi.org/10.5167/uzh-20942010.1038/s41467-021-24285-4Test
https://www.zora.uzh.ch/id/eprint/209420Test/
https://www.zora.uzh.ch/id/eprint/209420/1/41467_2021_Article_24285.pdfTest

المؤلفون: Maekelae, Anna R, Ugurlu, Hasan, Hannula, Liina, Kant, Ravi, Salminen, Petja, Fagerlund, Riku, Maeki, Sanna, Haveri, Anu, Strandin, Tomas, Kareinen, Lauri, Hepojoki, Jussi, Kuivanen, Suvi, Levanov, Lev, Pasternack, Arja, Naves, Rauno A, Ritvos, Olli, oesterlund, Pamela, Sironen, Tarja, Vapalahti, Olli, Kipar, Anja, Huiskonen, Juha T, Rissanen, Ilona, Saksela, Kalle

وصف الملف: application/pdf

العلاقة: http://livrepository.liverpool.ac.uk/3170184/1/Intranasal%20trimeric%20sherpabody%20inhibits%20SARS-CoV-2%20including%20recent%20immunoevasive%20Omicron%20subvariants.pdfTest; Collapse authors list. Maekelae, Anna R, Ugurlu, Hasan, Hannula, Liina, Kant, Ravi, Salminen, Petja, Fagerlund, Riku, Maeki, Sanna, Haveri, Anu, Strandin, Tomas, Kareinen, Lauri et al (show 13 more authors) , Hepojoki, Jussi, Kuivanen, Suvi, Levanov, Lev, Pasternack, Arja, Naves, Rauno A, Ritvos, Olli, oesterlund, Pamela, Sironen, Tarja, Vapalahti, Olli, Kipar, Anja orcid:0000-0001-7289-3459 , Huiskonen, Juha T, Rissanen, Ilona and Saksela, Kalle (2023) Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants. NATURE COMMUNICATIONS, 14 (1). 1637-.

الإتاحة: https://doi.org/10.1038/s41467-023-37290-6Test
http://livrepository.liverpool.ac.uk/3170184Test/
http://livrepository.liverpool.ac.uk/3170184/1/Intranasal%20trimeric%20sherpabody%20inhibits%20SARS-CoV-2%20including%20recent%20immunoevasive%20Omicron%20subvariants.pdfTest

المؤلفون: Maekelae, Anna R., Ugurlu, Hasan, Hannula, Liina, Kant, Ravi, Salminen, Petja, Fagerlund, Riku, Maeki, Sanna, Haveri, Anu, Strandin, Tomas, Kareinen, Lauri, Hepojoki, Jussi, Kuivanen, Suvi, Levanov, Lev, Pasternack, Arja, Naves, Rauno A., Ritvos, Olli, oesterlund, Pamela, Sironen, Tarja, Vapalahti, Olli, Kipar, Anja, Huiskonen, Juha T., Rissanen, Ilona, Saksela, Kalle

المصدر: WOS ; WOS:000959887700001

العلاقة: NATURE COMMUNICATIONS; 14; https://www.julkari.fi/handle/10024/146459Test

الإتاحة: https://www.julkari.fi/handle/10024/146459Test